Otsuka (OSUKF) Stock Price, News & Analysis

Company Overview

Otsuka Holdings Co., Ltd. is a Japanese healthcare company headquartered in Tokyo. Through its subsidiaries, the company conducts pharmaceutical and nutraceutical businesses, with a focus on developing products for unmet medical needs and promoting everyday health and well-being.

Its pharmaceutical operations cover areas including psychiatry, neurology, oncology, cardiovascular and renal medicine, and several other specialties. The company’s portfolio has included prescription medicines such as Abilify, Rexulti, Jinarc and Samsca, although product availability and marketing rights vary by country. Otsuka also develops and markets consumer health and nutraceutical products, including the Pocari Sweat hydration beverage and Nature Made nutritional supplements.

Otsuka serves customers in Japan and international markets across North America, Europe, Asia and other regions through a network of research, manufacturing and commercial operations. The group traces its origins to Otsuka Pharmaceutical Co., Ltd., founded in 1964, while Otsuka Holdings was established as a holding company in 2008. Its businesses are supported by research and development activities in pharmaceuticals, nutrition and related healthcare fields.

Key Stats

• Today's Range: $20.00 to $20.00
• 50-Day Range: $20.00 to $20.00
• 52-Week Range: $19.00 to $21.57
• Volume: N/A
• Average Volume: 650 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Company Calendar

• Today: 10/13/2026
• Next Earnings (Estimated): 11/04/2026

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Technology
• Industry: Electronics & Computer Distribution
• Sub-Industry: N/A
• Current Symbol: OTCMKTS:OSUKF
• CIK: N/A
• Web: www.otsuka-shokai.co.jp
• Phone: 81 3 3264 7111
• Fax: N/A
• Employees: 9,421
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A